FDA Approvals - Affymax Announces FDA Advisory Committee to Review PeginesatideAffymax, Inc. (Nasdaq:AFFY)
Affymax Announces FDA Advisory Committee to Review Peginesatide
Affymax, Inc. (Nasdaq:AFFY) today announced that the U.S. Food and Drug Administrations (FDA) Oncologic ...